Cargando…

Epidermal growth factor receptor and notch signaling in non‐small‐cell lung cancer

Lung cancer is the most common reason of cancer deaths and about 85% of these are non‐small‐cell lung cancer. Currently, lung cancer therapy is mainly based on the tumor node metastasis (TNM) disease staging and tumor histological classification. Despite therapeutic innovations, the prognosis for lu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pancewicz‐Wojtkiewicz, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224843/ https://www.ncbi.nlm.nih.gov/pubmed/27770511 http://dx.doi.org/10.1002/cam4.944

Ejemplares similares

Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma
por: Wolle, Daniel, et al.
Publicado: (2014)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma
por: Kawana, Sachiko, et al.
Publicado: (2020)

Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance
por: Jotte, Robert M, et al.
Publicado: (2015)

Oxymatrine inhibits non–small cell lung cancer via suppression of EGFR signaling pathway
por: Li, Wei, et al.
Publicado: (2017)

Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer
por: Fintelmann, Florian J., et al.
Publicado: (2019)

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients
por: Li, Wen‐Qian, et al.
Publicado: (2021)

Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer
por: Elakad, Omar, et al.
Publicado: (2020)

Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth
por: Sengupta, Shreoshi, et al.
Publicado: (2022)

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation
por: Chu, Qiaoyun, et al.
Publicado: (2021)

MPDZ promotes DLL4-induced Notch signaling during angiogenesis
por: Tetzlaff, Fabian, et al.
Publicado: (2018)

Epidermal growth factor receptors in non-small cell lung cancer.
por: Veale, D., et al.
Publicado: (1987)

Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations
por: Wong, Nelson K Y, et al.
Publicado: (2012)

Real‐world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non‐small cell lung cancer
por: Jiang, Shirley Xue, et al.
Publicado: (2019)

Screening common signaling pathways associated with drug resistance in non‐small cell lung cancer via gene expression profile analysis
por: Sun, Ting, et al.
Publicado: (2019)

Long noncoding RNA PART1 promotes progression of non‐small cell lung cancer cells via JAK‐STAT signaling pathway
por: Zhu, Dengyan, et al.
Publicado: (2019)

Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling
por: Lu, Lili, et al.
Publicado: (2016)

Current views on the role of Notch signaling and the pathogenesis of human leukemia
por: Pancewicz, Joanna, et al.
Publicado: (2011)

Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma
por: Liao, Yuwei, et al.
Publicado: (2019)

ZNF703 Overexpression may act as an oncogene in non‐small cell lung cancer
por: Baykara, Onur, et al.
Publicado: (2016)

Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
por: Qin, Angel, et al.
Publicado: (2016)

Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)

The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures
por: Balážová, Katarína, et al.
Publicado: (2023)

LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial–mesenchymal transition through the Notch1 signaling pathway
por: Liu, Wenxue, et al.
Publicado: (2018)

Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B)
por: Hu, Jiangfeng, et al.
Publicado: (2019)

Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non‐small cell lung cancer
por: Li, Xiaohui, et al.
Publicado: (2019)

YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways
por: Song, Yongchun, et al.
Publicado: (2019)

Metformin synergistic pemetrexed suppresses non‐small‐cell lung cancer cell proliferation and invasion in vitro
por: Zhang, Yan, et al.
Publicado: (2017)

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
por: Palumbo, Giuliano, et al.
Publicado: (2020)

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
por: Meder, Lydia, et al.
Publicado: (2015)

Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer
por: Watanabe, Kousuke, et al.
Publicado: (2015)

Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer
por: Salomonsson, Annette, et al.
Publicado: (2020)

Revealing the subtyping of non‐small cell lung cancer based on genomic evolutionary patterns by multi‐region sequencing
por: Liao, Gaoming, et al.
Publicado: (2020)

An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma
por: Oyelakin, Akinsola, et al.
Publicado: (2023)

Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer
por: Purcell, Emma, et al.
Publicado: (2021)

Systematic analysis of concentrations of 52 elements in tumor and counterpart normal tissues of patients with non‐small cell lung cancer
por: Cheng, Xin, et al.
Publicado: (2019)

Mechanical disruption of E-cadherin complexes with epidermal growth factor receptor actuates growth factor–dependent signaling
por: Sullivan, Brendan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g6sg61hnggv3s750bmpugjr0gc